scispace - formally typeset
S

Sandra L. Gray

Researcher at Clemson University

Publications -  24
Citations -  669

Sandra L. Gray is an academic researcher from Clemson University. The author has contributed to research in topics: Insulin-like growth factor & Estrogen receptor. The author has an hindex of 13, co-authored 24 publications receiving 637 citations.

Papers
More filters
Journal ArticleDOI

Vitellogenin induction in painted turtle, Chrysemys picta, as a biomarker of exposure to environmental levels of estradiol.

TL;DR: Assessment of levels of xenoestrogens found in ponds near livestock pastures concluded that males would not typically be sensitized in the wild and environmentally relevant levels of E(2) may not be sufficient to affect them, but higher VTG levels in females could potentially change their reproductive fitness by altering egg size or by shifting energy allocations away from other survival needs.
Journal ArticleDOI

Identification of Insulin-Like Growth Factor I in Bovine Seminal Plasma and Its Receptor on Spermatozoa: Influence on Sperm Motility

TL;DR: Computer-assisted sperm-motion analysis was used to determine the effects of IGF-I and IGF-II on bovine sperm motility parameters, and it was found that both IGFs increased sperm Motility and straight-line velocity relative to the control.
Journal ArticleDOI

The insulin-like growth factor (IGF) system and gonadotropin regulation: actions and interactions.

TL;DR: The influence of the IGF system on reproductive parameters, specifically gonadotropin release and interactions between the IGF System and other effectors of gonadotropic release will be examined in this review.
Journal ArticleDOI

Mycotoxins in root extracts of American and Asian ginseng bind estrogen receptors alpha and beta.

TL;DR: Ginseng extraction methods, plant species tested, and mycotoxin contaminants may help to explain the disparate literature reports, and the prevalence and health significance of fungal contamination in herbal products used for medicinal purposes should be further investigated.
Journal ArticleDOI

The contribution of hepatic steroid metabolism to serum estradiol and estriol concentrations in nonylphenol treated MMTVneu mice and its potential effects on breast cancer incidence and latency

TL;DR: 4‐NP treatment for 32 weeks increased mammary cancer formation at a dose of 45 mg kg−1 day−1 and suggests that nonylphenol is more potent than predicted based on its affinity for the estrogen receptor, but no changes in serum E3 concentrations or hepatic E3 production were measured after the chronic treatment.